Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in children aged 10-12 years: phase III randomized trial complementary analysis of immune persistence 3-6 years after priming
- jeanfrancoismaison
- 1 day ago
- 1 min read
top of page
Search
Recent Posts
See Allhttps://pubmed.ncbi.nlm.nih.gov/40443365/
https://pubmed.ncbi.nlm.nih.gov/40444990/
bottom of page
Comments